Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine

Brain

Volumn 139, Issue 12, 2016, Pages 3281-3295

  Kantrowitz, Joshua T ^a,b   Epstein, Michael L ^a,c   Beggel, Odeta ^a   Rohrig, Stephanie ^a   Lehrfeld, Jonathan M ^a   Revheim, Nadine ^a   Lehrfeld, Nayla P ^a   Reep, Jacob ^a   Parker, Emily ^a   Silipo, Gail ^a   Ahissar, Merav ^d   Javitt, Daniel C ^a,b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Clinical trials; Cortical plasticity; Imaging; Schizophrenia; Social cognition

Indexed keywords

BENZATROPINE; CHLORPROMAZINE; CLOZAPINE; DEXTRO SERINE; DIPHENHYDRAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OLANZAPINE; PLACEBO; QUETIAPINE; TRIHEXYPHENIDYL; AMINO ACID RECEPTOR STIMULATING AGENT; SERINE;

ADULT; ARTICLE; AUDITORY CORTEX; AUDITORY EVOKED POTENTIAL; AUDITORY NERVOUS SYSTEM; AUDITORY PLASTICITY; AUDITORY SYSTEM FUNCTION; AUDITORY SYSTEM PARAMETERS; BEHAVIOR; BETA RHYTHM; BRAIN ELECTROPHYSIOLOGY; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CONTINGENT NEGATIVE VARIATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTROENCEPHALOGRAM; EVENT RELATED TIME FREQUENCY; FEMALE; FUNCTIONAL DISEASE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MENTALLY DISABLED PERSON; MISMATCH NEGATIVITY; NERVE CELL PLASTICITY; NERVOUS SYSTEM PARAMETERS; NEUROMODULATION; NEUROPHYSIOLOGY; OCCUPATIONAL DISEASE; OPEN STUDY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SENSORY DYSFUNCTION; SOCIAL DISABILITY; THETA RHYTHM; AGONISTS; DIET THERAPY; DRUG EFFECTS; MIDDLE AGED; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; PHYSIOLOGY; PSYCHOTIC DISORDERS;

ADULT; AUDITORY PERCEPTUAL DISORDERS; BRAIN WAVES; COHORT STUDIES; EVOKED POTENTIALS, AUDITORY; EXCITATORY AMINO ACID AGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURONAL PLASTICITY; PSYCHOTIC DISORDERS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SERINE;

EID: 85010970290     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aww262     Document Type: Article

References (80)

1. Adcock RA, Dale C, Fisher M, Aldebot S, Genevsky A, Simpson G, et al. When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. Schizophr Bull 2009; 35: 1132-41.
2. Ahissar M. Perceptual training: a tool for both modifying the brain and exploring it. Proc Natl Acad Sci USA 2001; 98: 11842-3.
3. Ahissar M, Lubin Y, Putter-Katz H, Banai K. Dyslexia and the failure to form a perceptual anchor. Nat Neurosci 2006; 9: 1558-64.
4. Ahissar M, Nahum M, Nelken I, Hochstein S. Reverse hierarchies and sensory learning. Philos Trans R Soc Lond Ser B Biol Sci 2009; 364: 285-99.
5. Avellar M, Scoriels L, Madeira C, Vargas-Lopes C, Marques P, Dantas C, et al. The effect of D-serine administration on cognition and mood in older adults. Oncotarget 2016; 7: 11881-8.
6. Bickel S, Dias EC, Epstein ML, Javitt DC. Expectancy-related modulations of neural oscillations in continuous performance tasks. NeuroImage. 2012; 62: 1867-76.
7. Bodatsch M, Brockhaus-Dumke A, Klosterkotter J, Ruhrmann S. Forecasting psychosis by event-related potentials-systematic review and specific meta-analysis. Biol Psychiatry 2015; 77: 951-8.
8. Boehm U, van Maanen L, Forstmann B, van Rijn H. Trial-by-trial fluctuations in CNV amplitude reflect anticipatory adjustment of response caution. NeuroImage 2014; 96: 95-105.
9. Bowie CR, Reichenberg A, Patterson TL, Heaton RK, Harvey PD. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry 2006; 163: 418-25.
10. Burgos-Robles A, Vidal-Gonzalez I, Santini E, Quirk GJ. Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex. Neuron 2007; 53: 871-80.
11. Cain CK, McCue M, Bello I, Creedon T, Tang DI, Laska E, et al. d-Cycloserine augmentation of cognitive remediation in schizophrenia. Schizophr Res 2014; 153: 177-83.
12. Chennu S, Noreika V, Gueorguiev D, Blenkmann A, Kochen S, Ibanez A, et al. Expectation and attention in hierarchical auditory prediction. J Neurosci 2013; 33: 11194-205.
13. Cohen Y, Daikhin L, Ahissar M. Perceptual learning is specific to the trained structure of information. J Cogn Neurosci 2013; 25: 2047-60.
14. Crowley KE, Colrain IM. A review of the evidence for P2 being an independent component process: age, sleep and modality. Clin Neurophysiol 2004; 115: 732-44.
15. Daikhin L, Ahissar M. Fast learning of simple perceptual discriminations reduces brain activation in working memory and in high-level auditory regions. J Cogn Neurosci 2015; 27: 1308-21.
16. Dale CL, Brown EG, Fisher M, Herman AB, Dowling AF, Hinkley LB, et al. Auditory cortical plasticity drives training-induced cognitive changes in schizophrenia. Schizophr Bull 2016; 42: 220-8.
17. Dias EC, Bickel S, Epstein ML, Sehatpour P, Javitt DC. Abnormal task modulation of oscillatory neural activity in schizophrenia. Front Psychol 2013; 4: 540.
18. Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods 2004; 134: 9-21.
19. Edwards J, Pattison PE, Jackson HJ, Wales RJ. Facial affect and affective prosody recognition in first-episode schizophrenia. Schizophr Res 2001; 48: 235-53.
20. Erickson MA, Ruffle A, Gold JM. A meta-analysis of mismatch negativity in schizophrenia: from clinical risk to disease specificity and progression. Biol Psychiatry 2016; 79: 980-7.
21. Fisher M, Holland C, Merzenich MM, Vinogradov S. Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. Am J Psychiatry 2009; 166: 805-11.
22. Friedman T, Sehatpour P, Dias E, Perrin M, Javitt DC. Differential relationships of mismatch negativity and visual P1 deficits to premorbid characteristics and functional outcome in schizophrenia. Biol Psychiatry 2012; 71: 521-9.
23. Gil-da-Costa R, Stoner GR, Fung R, Albright TD. Nonhuman primate model of schizophrenia using a noninvasive EEG method. Proc Natl Acad Sci USA 2013; 110: 15425-30.
24. Goff D. The therapeutic role of d-Cycloserine in schizophrenia. Adv Pharmacol 2016; 76: 39-66.
25. Goff DC, Hill M, Barch D. The treatment of cognitive impairment in schizophrenia. Pharmacol Biochem Behav 2011; 99: 245-53.
26. Gold R, Butler PD, Revheim N, Leitman DI, Hansen JA, Gur RC, et al. Auditory emotion recognition impairments in Schizophrenia: relationship to acoustic features and cognition. Am J Psychiatry 2012; 169: 424-32.
27. Gonzalez-Burgos G, Lewis DA. NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr Bull 2012; 38: 950-7.
28. Gottlieb JD, Cather C, Shanahan M, Creedon T, Macklin EA, Goff DC. D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia. Schizophr Res 2011; 131: 69-74.
29. Green MF, Hellemann G, Horan WP, Lee J, Wynn JK. From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. Arch Gen Psychiatry 2012; 69: 1216-24.
30. Green MF, Horan WP, Lee J. Social cognition in schizophrenia. Nat Rev Neurosci 2015; 16: 620-31.
31. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull 2000; 26: 119-36.
32. Gunduz-Bruce H, Reinhart RM, Roach BJ, Gueorguieva R, Oliver S, D'Souza DC, et al. Glutamatergic modulation of auditory information processing in the human brain. Biol Psychiatry 2012; 71: 969-77.
33. Hunt DL, Castillo PE. Synaptic plasticity of NMDA receptors: mechanisms and functional implications. Curr Opin Neurobiol 2012; 22: 496-508.
34. Jaffe-Dax S, Raviv O, Jacoby N, Loewenstein Y, Ahissar M. A Computational model of implicit memory captures dyslexics' perceptual deficits. J Neurosci 2015; 35: 12116-26.
35. Javitt DC. Harnessing N-methyl-d-aspartate receptors for new treatment development in psychiatry: positive lessons from negative studies. Am J Psychiatry 2013; 170: 699-702.
36. Javitt DC, Freedman R. Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia. Am J Psychiatry 2015; 172: 17-31.
37. Javitt DC, Shelley A, Ritter W. Associated deficits in mismatch negativity generation and tone matching in schizophrenia. Clin Neurophysiol 2000; 111: 1733-7.
38. Javitt DC, Steinschneider M, Schroeder CE, Arezzo JC. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci USA 1996; 93: 11962-7.
39. Javitt DC, Sweet RA. Auditory dysfunction in schizophrenia: integrating clinical and basic features. Nat Rev Neurosci 2015; 16: 535-50.
40. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991; 148: 1301-8.
41. Kantrowitz JT, Sharif Z, Medalia A, Keefe RSE, Harvey PD, Bruder GE, et al. A multicenter, rater-blind, randomized controlled study of auditory processing focused cognitive remediation combined with open label lurasidone in patients with schizophrenia and schizoaffective disorder. J Clin Psychiatry 2016; 77: 799-806.
42. Kantrowitz JT, Hoptman MJ, Leitman DI, Moreno-Ortega M, Lehrfeld JM, Dias E, et al. Neural substrates of auditory emotion recognition deficits in schizophrenia. J Neurosci 2015; 35: 14909-21.
43. Kantrowitz JT, Hoptman MJ, Leitman DI, Silipo G, Javitt DC. The 5% difference: early sensory processing predicts sarcasm perception in schizophrenia and schizo-affective disorder. Psychol Med 2014; 44: 25-36.
44. Kantrowitz JT, Javitt DC. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull 2010; 83: 108-21 PMC2941541.
45. Kantrowitz JT, Javitt DC. Glutamatergic approaches to the conceptualization and treatment of schizophrenia. In: Javitt DC, Kantrowitz JT, editors. Handbook of neurochemistry and molecular neurobiology. . New York: Springer; 2009.
46. Kantrowitz JT, Scaramello N, Jakubovitz A, Lehrfeld JM, Laukka P, Elfenbein HA, et al. Amusia and protolanguage impairments in schizophrenia. Psychol Med 2014; 44: 2739-48.
47. Kantrowitz JT, Woods SW, Petkova E, Cornblatt B, Corcoran CM, Chen H, et al. D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial. Lancet Psychiatry 2015; 2: 403-12.
48. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994; 51: 199-214.
49. Liu X, Gu QH, Duan K, Li Z. NMDA receptor-dependent LTD is required for consolidation but not acquisition of fear memory. J Neurosci 2014; 34: 8741-8.
50. Leitman DI, Hoptman MJ, Foxe JJ, Saccente E, Wylie GR, Nierenberg J, et al. The neural substrates of impaired prosodic detection in schizophrenia and its sensorial antecedents. Am J Psychiatry 2007; 164: 474-82.
51. Leitman DI, Sehatpour P, Higgins BA, Foxe JJ, Silipo G, Javitt DC. Sensory deficits and distributed hierarchical dysfunction in schizophrenia. Am J Psychiatry 2010; 167: 818-27.
52. Levin R, Dor-Abarbanel AE, Edelman S, Durrant AR, Hashimoto K, Javitt DC, et al. Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: initial findings. J Psychiatric Res 2015; 61: 188-95.
53. Light GA, Swerdlow NR. Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia. Ann N Y Acad Sci 2015; 1344: 105-19.
54. Light GA, Swerdlow NR, Rissling AJ, Radant A, Sugar CA, Sprock J, et al. Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia. PLoS One 2012; 7: e39434.
55. Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 2008; 31: 234-42 PMCID: PMC2680493.
56. Luscher C, Malenka RC. NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD). Cold Spring Harbo perspect Bio 2012; 4.
57. Oganian Y, Ahissar M. Poor anchoring limits dyslexics' perceptual, memory, and reading skills. Neuropsychologia 2012; 50: 1895-905.
58. Ori R, Amos T, Bergman H, Soares-Weiser K, Ipser JC, Stein DJ. Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders. Cochrane Database Syst Rev 2015; 5: CD007803.
59. Nahum M, Daikhin L, Lubin Y, Cohen Y, Ahissar M. From comparison to classification: a cortical tool for boosting perception. J Neurosci 2010; 30: 1128-36.
60. Popov TG, Carolus A, Schubring D, Popova P, Miller GA, Rockstroh BS. Targeted training modifies oscillatory brain activity in schizophrenia patients. NeuroImage Clin 2015; 7: 807-14.
61. Popov T, Rockstroh B, Weisz N, Elbert T, Miller GA. Adjusting brain dynamics in schizophrenia by means of perceptual and cognitive training. PLoS One 2012; 7: e39051.
62. Quartermain D, Mower J, Rafferty MF, Herting RL, Lanthorn TH. Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention. Eur J Pharmacol 1994; 257: 7-12.
63. Revheim N, Corcoran CM, Dias E, Hellmann E, Martinez A, Butler PD, et al. Reading deficits in schizophrenia and individuals at high clinical risk: relationship to sensory function, course of illness, and psychosocial outcome. Am J Psychiatry 2014; 171: 949-59.
64. Roth W, Cannon E. Some features of the auditory evoked response in schizophrenics. Arch Gen Psychiatry 1972; 27: 466-71.
65. Santini E, Muller RU, Quirk GJ. Consolidation of extinction learning involves transfer from NMDA-independent to NMDA-dependent memory. J Neurosci 2001; 21: 9009-17.
66. Shelley AM, Ward PB, Catts SV, Michie PT, Andrews S, McConaghy N. Mismatch negativity: an index of a preattentive processing deficit in schizophrenia. Biol Psychiatry 1991; 30: 1059-62.
67. Small JG, Small IF. Contingent negative variation (CNV). Correlations with psychiatric diagnosis. Arch Gen Psychiatry 1971; 25: 550-4.
68. Todd J, Harms L, Schall U, Michie PT. Mismatch negativity: translating the potential. Front Psychiatry 2013; 4: 171.
69. Umbricht D, Krljes S. Mismatch negativity in schizophrenia: a meta-analysis. Schizophr Res 2005; 76: 1-23.
70. Umbricht D, Javitt D, Novak G, Bates J, Pollack S, Lieberman J, et al. Effects of clozapine on auditory event-related potentials in schizophrenia. Biol Psychiatry 1998; 44: 716-25.
71. Umbricht D, Javitt D, Novak G, Bates J, Pollack S, Lieberman J, et al. Effects of risperidone on auditory event-related potentials in schizophrenia. Int J Neuropsychopharmacol 1999; 2: 299-304.
72. Umbricht D, Schmid L, Koller R, Vollenweider FX, Hell D, Javitt DC. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry 2000; 57: 1139-47.
73. Vinogradov S, Fisher M, de Villers-Sidani E. Cognitive training for impaired neural systems in neuropsychiatric illness. Neuropsychopharmacology 2012; 37: 43-76.
74. Wagstyl K, Ronan L, Whitaker KJ, Goodyer IM, Roberts N, Crow TJ, et al. Multiple markers of cortical morphology reveal evidence of supragranular thinning in schizophrenia. Transl Psychiatry 2016; 6: e780.
75. Wagner RK, Torgesen JK, Rashotte CA. CTOPP: comprehensive test of phonological processing (Examiner's Manual.). Austin, TX: Pro-Ed; 1999.
76. Watt AJ, Sjostrom PJ, Hausser M, Nelson SB, Turrigiano GG. A proportional but slower NMDA potentiation follows AMPA potentiation in LTP. Nat Neurosci 2004;7 : 518-24.
77. Wechsler DA. Wechsler adult intelligence scale-III. New York: Psychological Corporation; 1997.
78. Womelsdorf T, Everling S. Long-range attention networks: circuit motifs underlying endogenously controlled stimulus selection. Trends Neurosci 2015; 38: 682-700.
79. Womelsdorf T, Valiante TA, Sahin NT, Miller KJ, Tiesinga P. Dynamic circuit motifs underlying rhythmic gain control, gating and integration. Nat Neurosci 2014; 17: 1031-9.
80. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003; 64: 663-7.